EPHA2 and neoplasm: While ligand-dependent EphA2-activation has been considered tumor suppressive, recent reports have highlighted a role for EphA2-ephrin-A1 signaling in tumor cell plasticity and a shift from mesenchymal to amoeboid morphology [5, 6] and increased single cell invasion [7].